The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background
An increased dietary fructose intake has been shown to exert several detrimental metabolic effects and contribute to the pathogenesis of nonalcoholic fatty liver disease (NAFLD). An augmented intestinal abundance of the fructose carriers glucose transporter‐5 (GLUT‐5) and glucose transporter‐2 (GLUT‐2) has been found in subjects with obesity and type 2 diabetes. Herein, we investigated...
Objective
Prior evidence indicates that individuals with obesity have an accelerated intestinal glucose absorption. This cross‐sectional study evaluated whether those with overweight or obesity display higher duodenal protein levels of the glucose carriers sodium‐glucose cotransporter 1 (SGLT‐1), glucose transporter 2 (GLUT‐2), and glucose transporter 5 (GLUT‐5).
Methods
SGLT‐1, GLUT‐2, and GLUT‐5...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.